Statistics for Regencell Bioscience Holdings Limited (id:5375 RGC)
Valuation metrics
Market cap
64.02M
Enterprise value
56.15M
Trailing P/E (ttm)
Forward P/E
PEG ratio
Price/Sales (ttm)
Price/Book (mrq)
7.78
Enterprise Value/Revenue
Enterprise Value/EBITDA
-12.67
Overview
Shares outstanding
13.01M
Float
1.44M
Shares short
26.35K
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
16.86K
Average volume (90 days)
Price summary
52-Week low
3.03
52-Week high
32.44
52-Week change
-87.50%
Beta
3.00
50-Day moving average
5.91
200-Day moving average
5.72
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
June 30, 2024
Most recent quarter (mrq)
June 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-28.11%
Return on equity
-43.18%
Income statement
Revenue (ttm)
Revenue per share (ttm)
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-4,430,946.00
Net income to common (ttm)
-4,301,837.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
7.96M
Total cash per share (mrq)
3.00
Total debt (mrq)
85.74K
Total Debt/Equity (mrq)
1.04
Current ratio (mrq)
4.19K%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-4,001,687.00
Levered free cash flow (LFCF)
-1,881,352.00